Literature DB >> 33387058

Eyelid myoclonia with absences, intellectual disability and attention deficit hyperactivity disorder: a clinical phenotype of the RORB gene mutation.

Antonella Morea1, G Boero2, V Demaio3, T Francavilla3, A La Neve3.   

Abstract

Eyelid myoclonia with absences is recently included in the category of childhood epileptic syndromes. It is clinically characterized by brief seizures of eyelid myoclonia, sometimes followed by absences, and it is associated to EEG generalized discharges of polyspikes or polyspike-waves, which are triggered by eyes closure in a well-lit room. This epileptic syndrome probably has a genetic origin, as well as other genetic generalized epilepsies, in particular photosensitive epilepsies. We describe the case of a patient affected by eyelid myoclonia with absences, intellectual disability, and attention deficit hyperactivity disorder (ADHD), with a de novo mutation of the RORB gene (retinoid-related orphan receptor β); this gene is involved in vivo in different neuronal processes among which are migration and differentiation. We suggest that its mutation in our patient can be considered the cause of the aberrant functioning of the cerebral cortex, which is clinically expressed by epilepsy and neurodevelopment disorders.

Entities:  

Keywords:  Eyelid myoclonia with absences; Intellectual disability; Photosensitivity; RORB gene

Year:  2021        PMID: 33387058     DOI: 10.1007/s10072-020-05031-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  2 in total

1.  Case Report: A Case of Eyelid Myoclonic Status With Tonic-Clonic Seizure and Literature Review.

Authors:  Yujun Yuan; Fenghua Yang; Liang Huo; Yuying Fan; Xueyan Liu; Qiong Wu; Hua Wang
Journal:  Front Pediatr       Date:  2021-04-22       Impact factor: 3.418

Review 2.  Candidate Genes for Eyelid Myoclonia with Absences, Review of the Literature.

Authors:  Sonia Mayo; Irene Gómez-Manjón; Fco Javier Fernández-Martínez; Ana Camacho; Francisco Martínez; Julián Benito-León
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.